241 related articles for article (PubMed ID: 25937178)
1. Oxidative stress in paroxysmal nocturnal hemoglobinuria and other conditions of complement-mediated hemolysis.
Fibach E; Dana M
Free Radic Biol Med; 2015 Nov; 88(Pt A):63-9. PubMed ID: 25937178
[TBL] [Abstract][Full Text] [Related]
2. Oxidative status of red blood cells, neutrophils, and platelets in paroxysmal nocturnal hemoglobinuria.
Amer J; Zelig O; Fibach E
Exp Hematol; 2008 Apr; 36(4):369-77. PubMed ID: 18261835
[TBL] [Abstract][Full Text] [Related]
3. Paroxysmal nocturnal hemoglobinuria and the complement system: recent insights and novel anticomplement strategies.
Risitano AM
Adv Exp Med Biol; 2013; 735():155-72. PubMed ID: 23402025
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic complement inhibition in complement-mediated hemolytic anemias: Past, present and future.
Risitano AM; Marotta S
Semin Immunol; 2016 Jun; 28(3):223-40. PubMed ID: 27346521
[TBL] [Abstract][Full Text] [Related]
5. [Novel therapeutic agents for hemolytic anemia].
Nishimura JI
Rinsho Ketsueki; 2023; 64(9):884-891. PubMed ID: 37793862
[TBL] [Abstract][Full Text] [Related]
6. Extravascular hemolysis and complement consumption in Paroxysmal Nocturnal Hemoglobinuria patients undergoing eculizumab treatment.
Subías Hidalgo M; Martin Merinero H; López A; Anter J; García SP; Ataúlfo Gonzalez-Fernández F; Forés R; Lopez-Trascasa M; Villegas A; Ojeda E; Rodríguez de Córdoba S
Immunobiology; 2017 Feb; 222(2):363-371. PubMed ID: 27644115
[TBL] [Abstract][Full Text] [Related]
7. Paroxysmal nocturnal hemoglobinuria and other complement-mediated hematological disorders.
Risitano AM
Immunobiology; 2012 Nov; 217(11):1080-7. PubMed ID: 22964233
[TBL] [Abstract][Full Text] [Related]
8. Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
Yuan X; Gavriilaki E; Thanassi JA; Yang G; Baines AC; Podos SD; Huang Y; Huang M; Brodsky RA
Haematologica; 2017 Mar; 102(3):466-475. PubMed ID: 27810992
[TBL] [Abstract][Full Text] [Related]
9. Paroxysmal nocturnal hemoglobinuria: a complement-mediated hemolytic anemia.
DeZern AE; Brodsky RA
Hematol Oncol Clin North Am; 2015 Jun; 29(3):479-94. PubMed ID: 26043387
[TBL] [Abstract][Full Text] [Related]
10. Molecular pharmacology in complement-mediated hemolytic disorders.
Bortolotti M; Barcellini W; Fattizzo B
Eur J Haematol; 2023 Sep; 111(3):326-336. PubMed ID: 37308291
[TBL] [Abstract][Full Text] [Related]
11. [Novel anti-complement therapeutics for hemolytic anemia].
Nishimura JI
Rinsho Ketsueki; 2023; 64(6):466-473. PubMed ID: 37407469
[TBL] [Abstract][Full Text] [Related]
12. Perisurgical induction of eculizumab in a patient with paroxysmal nocturnal hemoglobinuria: its inhibition of surgery-triggered hemolysis and the consequence of subsequent discontinuation.
Kurita N; Obara N; Fukuda K; Nishikii H; Sato S; Inagawa S; Kurokawa T; Owada Y; Ninomiya H; Chiba S
Blood Coagul Fibrinolysis; 2013 Sep; 24(6):658-62. PubMed ID: 23917586
[TBL] [Abstract][Full Text] [Related]
13. Properdin Is a Key Player in Lysis of Red Blood Cells and Complement Activation on Endothelial Cells in Hemolytic Anemias Caused by Complement Dysregulation.
Chen JY; Galwankar NS; Emch HN; Menon SS; Cortes C; Thurman JM; Merrill SA; Brodsky RA; Ferreira VP
Front Immunol; 2020; 11():1460. PubMed ID: 32793201
[TBL] [Abstract][Full Text] [Related]
14. Complement in hemolytic anemia.
Brodsky RA
Hematology Am Soc Hematol Educ Program; 2015; 2015():385-91. PubMed ID: 26637747
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of complement-mediated haemolysis in paroxysmal nocturnal haemoglobinuria by heparin or low-molecular weight heparin.
Ninomiya H; Kawashima Y; Nagasawa T
Br J Haematol; 2000 Jun; 109(4):875-81. PubMed ID: 10929045
[TBL] [Abstract][Full Text] [Related]
16. Paroxysmal nocturnal hemoglobinuria.
Parker CJ
Curr Opin Hematol; 2012 May; 19(3):141-8. PubMed ID: 22395662
[TBL] [Abstract][Full Text] [Related]
17. Drugs that inhibit complement.
Schrezenmeier H; Höchsmann B
Transfus Apher Sci; 2012 Feb; 46(1):87-92. PubMed ID: 22169380
[TBL] [Abstract][Full Text] [Related]
18. Complement in hemolytic anemia.
Brodsky RA
Blood; 2015 Nov; 126(22):2459-65. PubMed ID: 26582375
[TBL] [Abstract][Full Text] [Related]
19. The role of complement inhibition in PNH.
Hillmen P
Hematology Am Soc Hematol Educ Program; 2008; ():116-23. PubMed ID: 19074068
[TBL] [Abstract][Full Text] [Related]
20. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria.
Hillmen P; Hall C; Marsh JC; Elebute M; Bombara MP; Petro BE; Cullen MJ; Richards SJ; Rollins SA; Mojcik CF; Rother RP
N Engl J Med; 2004 Feb; 350(6):552-9. PubMed ID: 14762182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]